[Federal Register Volume 70, Number 219 (Tuesday, November 15, 2005)]
[Notices]
[Pages 69345-69346]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-22562]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Request for Nominations for Nonvoting Member Representing 
Industry Interests on a Public Advisory Committee; Nonprescription 
Drugs Advisory Committee

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is requesting 
nominations for a nonvoting industry representative to serve on the 
Nonprescription Drugs Advisory Committee.

DATES: All letters of interest and nominations should be received on or 
before December 15, 2005.

ADDRESSES: Letters of intent and nominations for membership should be 
submitted to Jayne Peterson (see FOR FURTHER INFORMATION CONTACT).

FOR FURTHER INFORMATION CONTACT: Jayne Peterson, Advisors and 
Consultants Staff (HFD-21), Center for Drug Evaluation and Research, 
Food and Drug Administration, 5600 Fishers Lane (for express delivery, 
5630 Fishers Lane, rm. 1093), Rockville, MD 20857, 301-827-7001, e-
mail: <a href="/cdn-cgi/l/email-protection#99e9fcedfcebeaf6f7f3d9fafdfcebb7fffdf8b7fef6ef"><span class="__cf_email__" data-cfemail="28584d5c4d5a5b474642684b4c4d5a064e4c49064f475e">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: The agency requests nominations for a 
nonvoting industry representative to serve on the Nonprescription Drugs 
Advisory Committee.

I. Function

    The function of the committee is to review and evaluate available 
data concerning the safety and effectiveness of over-the-counter 
(nonprescription) human drug products for use in the treatment of a 
broad spectrum of human symptoms and diseases.

II. Selection Procedure

    Any industry organization interested in participating in the 
selection of an appropriate nonvoting member to represent industry 
interests should send a letter stating that interest to the FDA contact 
(see FOR FURTHER INFORMATION CONTACT) within 30 days of publication of 
this notice. Within the subsequent 30 days, FDA will send a letter to 
each organization that has expressed an interest, attaching a complete 
list of all such organizations; and a list of all nominees along with 
their current resumes. The letter will also state that it is the 
responsibility of the interested

[[Page 69346]]

organizations to confer with one another and to select a candidate, 
within 60 days after the receipt of the FDA letter, to serve as the 
nonvoting member to represent industry interests for a particular 
committee. If no individual is selected within 60 days, the 
Commissioner of Food and Drugs will select the nonvoting member to 
represent industry interests.

III. Application Procedure

    Individuals may self nominate and/or an organization may nominate 
one or more individuals to serve as a nonvoting industry 
representative. A current curriculum vitae and the name of the 
committee of interest should be sent to the FDA contact person. FDA 
will forward all nominations to the organizations expressing interest 
in participating in the selection process for that committee. (Persons 
who nominate themselves as nonvoting industry representatives will not 
participate in the selection process.)
    FDA has a special interest in ensuring that women, minority groups, 
individuals with physical disabilities, and small businesses are 
adequately represented on its advisory committees, and therefore, 
encourages nominations for appropriately qualified candidates from 
these groups. Specifically, in this document, nominations for nonvoting 
representatives of industry interests are encouraged from drug 
manufacturing industry.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app 2) and 21 CFR part 14, relating to advisory committees.

    Dated: November 4, 2005.
Jason Brodsky,
Acting Associate Commissioner for External Relations.
[FR Doc. 05-22562 Filed 11-14-05; 8:45 am]
BILLING CODE 4160-01-S


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>